Search Results - "Crary, Shelley E"

Vascular complications after splenectomy for hematologic disorders by Crary, Shelley E., Buchanan, George R.

“…The most widely recognized long-term risk of splenectomy is overwhelming bacterial infection. More recently, thrombosis has become appreciated as another…”
Get full text

Comparative Effectiveness of Different Types of Splenectomy for Children with Congenital Hemolytic Anemias by Rice, Henry E., MD, Crary, Shelley E., MD, Langer, Jacob C., MD, Kemper, Alex R., MD, MPH, MS

“…Objective To compare the effectiveness of different types of splenectomy in children with congenital hemolytic anemias. Study design We constructed key…”
Get full text

Prominent Forehead Hematomas (“Goose-Eggs”) as an Initial Manifestation of Hemophilia by Plummer, Ellen S., MD, Crary, Shelley E., MD, MS, Buchanan, George R., MD

“…Prominent forehead hematomas, “goose-eggs,” may suggest an underlying disorder of coagulation. We reviewed records of 324 children with hemophilia and…”
Get full text

Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis by Crary, Shelley E., Troendle, Sarah, Ahmad, Naveed, Buchanan, George R.

“…Background Individuals who have undergone splenectomy may be at an increased risk of arterial and venous thrombosis. We sought to determine if splenectomy…”
Get full text

How we approach coagulopathy with vascular anomalies by Mack, Joana M., Crary, Shelley E.

“…Some vascular anomalies can present with challenging hematologic aberrations. Kaposiform hemangioendothelioma (KHE) may be complicated with Kasabach–Merritt…”
Get full text

A case of bruising and joint hypermobility: The need to consider genetic testing for platelet disorders by Citla‐Sridhar, Divyaswathi, Canonigo, Jared, Crary, Shelley E.

Get full text

Mental health in persons with von Willebrand disease in the United States – a large national database study by Tran, Andrew D., Waller, Emily, Mack, Joana M., Crary, Shelley E., Citla-Sridhar, Divyaswathi

“…There are very few large population-based studies studying mental health in persons with von Willebrand disease (PwVWD). We aim to assess prevalence of…”
Get full text

Effect of sirolimus on coagulopathy of slow‐flow vascular malformations by Mack, Joana M., Verkamp, Bethany, Richter, Gresham T., Nicholas, Richard, Stewart, Kelly, Crary, Shelley E.

“…Background/Objectives Stagnant blood flow present in slow‐flow vascular malformations can lead to localized intravascular coagulopathy (LIC), measured by…”
Get full text

Acquired Hemophilia: A Rare Complication of Pediatric Idiopathic Multicentric Castleman Disease by Appell, Lauren E, Mack, Joana M, Farrar, Jason E, Roper, Sydney N, Savage, Matthew R, Pandey, Soumya, Crary, Shelley E

“…Acquired hemophilia is caused by acquired autoantibodies to 1 of the factors of the coagulation cascade, usually factor VIII or IX, and is an exceedingly rare…”
Get full text

Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B by O’Connell, Niamh, van der Valk, Paul, Le Quellec, Sandra, Gomez, Esteban, Monahan, Paul E., Crary, Shelley E., Coppens, Michiel, Lemons, Richard, Castaman, Giancarlo, Klamroth, Robert, Symington, Emily, Quon, Doris V., Kampmann, Peter

“…Little information regarding the management of invasive procedures in people with hemophilia B (HB) after undergoing gene therapy is available. Here, we report…”
Get full text

Pupil Size and Reactivity in Pediatric Patients With Sickle Cell Disease by Mack, Joana M., Frankowski, Sara, Verkamp, Bethany, Crary, Shelley E., Spray, Beverly, Crawley, Lee, Saccente, Suzanne, Neville, Kathleen A.

“…Pupil size and reactivity have been studied to objectively measure pain utilizing pupillometry measurements. Given the challenges associated with treating…”
Get full text

Anticoagulation and vascular anomalies by Crary, Shelley E., Mack, Joana M.

“…A State of the Art lecture titled “Anticoagulation and Vascular Anomalies” was presented at the International Society on Thrombosis and Haemostasis (ISTH)…”
Get full text

Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations by Mack, Joana M., Peterson, Eric C., Crary, Shelley E., Moran, Jeffery H., Neville, Kathleen, Pierce, C. D'ann, Richter, Gresham T.

“…Bleomycin, a chemotherapy agent that inhibits synthesis of DNA, has been increasingly utilized in sclerotherapy for patients with vascular malformations. A…”
Get full text

Multiple Autoimmune Disorders in Aicardi-Goutières Syndrome by Samanta, Debopam, Ramakrishnaiah, Raghu, Crary, Shelley E., Sukumaran, Sukesh, Burrow, Thomas A.

“…Aicardi-Goutières syndrome is an early-onset encephalopathy with presumed immune pathogenesis caused by inherited defects in nucleic acid metabolism. It is a…”
Get full text

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy by Crary, Shelley E., Hall, Katherine, Buchanan, George R.

“…Background For decades, parenteral iron has been used in patients with iron deficiency unresponsive to oral iron therapy and in hemodialysis‐dependent patients…”
Get full text

Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study by Borst, Alexandra J., Eng, Whitney, Griffin, Morgan, Ricci, Kiersten W., Engel, Elissa, Adams, Denise M., Dayneka, Jillian, Cohen‐Cutler, Sally J., Andreoli, Steven M., Wu, Melinda D., Wheeler, Allison P., Heym, Kenneth M., Crary, Shelley E., Nakano, Taizo A., Schulte, Rachael R., Setty, Bhuvana A., McLean, Thomas W., Pahl, Kristy S., Intzes, Stefanos, Pateva, Irina, Teitelbaum, Max, Zong, Zili, Li, Yimei, Jeng, Michael R.

“…Background and objectives Kaposiform hemangioendothelioma (KHE) and tufted angioma (TA) are rare vascular tumors in children historically associated with…”
Get full text

Long‐term biological effects in sickle cell disease: insights from a post‐crizanlizumab study by Liles, Darla K., Shah, Nirmish R., Scullin, Brigid, Gordeuk, Victor R., Smith, Wally R., Kanter, Julie, Achebe, Maureen M., Boccia, Ralph, Crary, Shelley E., Kraft, Walter K., Archer, Natasha, Cataldo, Vince, Hardesty, Brandon M., Idowu, Modupe, Desai, Payal C., Ikeda, Alan, Puthenveetil, Geetha, Hassell, Kathryn L., Sarnaik, Sharada, Kutlar, Abdullah

Get full text

Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes by Grace, Rachael F., Shimano, Kristin A., Bhat, Rukhmi, Neunert, Cindy, Bussel, James B., Klaassen, Robert J., Lambert, Michele P., Rothman, Jennifer A., Breakey, Vicky R., Hege, Kerry, Bennett, Carolyn M., Rose, Melissa J., Haley, Kristina M., Buchanan, George R., Geddis, Amy, Lorenzana, Adonis, Jeng, Michael, Pastore, Yves D., Crary, Shelley E., Neier, Michelle, Neufeld, Ellis J., Neu, Nolan, Forbes, Peter W., Despotovic, Jenny M.

“…Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with isolated thrombocytopenia and hemorrhagic risk. While many children with ITP can be…”
Get full text

Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography by Mack, Joana M., Pierce, C. D'ann, Richter, Gresham T., Spray, Beverly J., Nicholas, Richard, Lewis, P. Spencer, Becton, David, Crary, Shelley E.

“…Background/Objectives Slow‐flow vascular malformations are abnormal vessels that can lead to activation and consumption of coagulation factors and thrombosis,…”
Get full text

Short‐term side effects and patient‐reported outcomes of bleomycin sclerotherapy in vascular malformations by Mack, Joana M., Richter, Gresham T., Becton, David, Salem, Omar, Hill, Sarah E. M., Crary, Shelley E.

“…Background Vascular malformations (VM) are congenital lesions that can be debilitating and cause significant aesthetic and functional limitations. The…”
Get full text